Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Omics Analysis Reveals a CD206+ Macrophage/Dendritic Cell-CD155-TIGIT+ Regulatory T Cell Axis as a Protective Immune Checkpoint Pathway in Atherosclerosis Progression. | Barrier Immun | 2026 | 42819567 | PubTator, text mining | PubMed |
| Radiation-induced SLAMF1 reconfigures the SLAM family receptors landscape in triple-negative breast cancer cells. | J Cancer | 2026 | 42807708 | PubTator, text mining | PubMed |
| Alternative splicing of CD244 restrains natural killer cells at the maternal-fetal interface. | Mucosal Immunol | 2026 | 42805341 | PubTator, text mining | PubMed |
| Dual targeting of CD244 and CD2 by a viral-immunoevasin-guided engineered CD48-Fc mutant for T- and NK-cell modulation. | Front Immunol | 2026 | 42746293 | PubTator, text mining | PubMed |
| Role of spin-orbit and nuclear motion assisted spin-orbit coupling on the structural isomerism dependent intersystem crossing mechanism. | J Chem Phys | 2026 | 42635283 | PubTator, text mining | PubMed |
| Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy. | Haematologica | 2026 | 42610426 | PubTator, text mining | PubMed |
| CD48 and CXCR4 as immune-associated biomarkers in periodontitis: an integrative analysis and validation study. | Front Immunol | 2026 | 42465757 | PubTator, text mining | PubMed |
| CD48 expression in T-lymphoblastic leukemia/lymphoma and mature T-cell neoplasms: role in detecting measurable residual disease and potential confounders, a single-institution retrospective review. | Am J Clin Pathol | 2026 | 42269000 | PubTator, text mining | PubMed |
| Exploring the gut-lung axis in post-liver transplant acute lung injury: A multi-omics approach. | Acta Microbiol Immunol Hung | 2026 | 42258310 | PubTator, text mining | PubMed |
| Extending structural surfaceomics to identify aberrant conformations of tumor surface proteins as potential immunotherapy targets. | bioRxiv | 2026 | 42239335 | PubTator, text mining | PubMed |
| Niche-level immune evasion in TP53 mutant AML residual disease revealed by spatial proteomics. | bioRxiv | 2026 | 42239259 | PubTator, text mining | PubMed |
| CLIP2 is a potential biomarker for platinum resistance and prognosis in ovarian cancer: a bioinformatics analysis. | Transl Cancer Res | 2026 | 42180947 | PubTator, text mining | PubMed |
| A comparison of two manufacturing methods in the phase I COBALT study of CD19CAR T for LBCL. | Mol Ther Adv | 2026 | 42137288 | PubTator, text mining | PubMed |
| Differences in gene expression may contribute to the racial differences in the risk of MASLD. | PLoS One | 2026 | 42081492 | PubTator, text mining | PubMed |
| Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response. | Blood Cancer J | 2026 | 42020367 | PubTator, text mining | PubMed |
| CD48+ tumour-associated macrophages: novel immunotherapeutic targets in hepatocellular carcinoma. | Gut | 2026 | 42014189 | PubTator, text mining | PubMed |
| Variants in human CD48 lead to impaired T cell immunity and increased inflammation. | J Clin Invest | 2026 | 41984595 | PubTator, text mining | PubMed |
| Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps. | J Allergy Clin Immunol | 2026 | 41956382 | PubTator, text mining | PubMed |
| Cuproptosis in spinal cord injury: emerging mechanisms and immunological relevance. | Ann Med | 2026 | 41883033 | PubTator, text mining | PubMed |
| HO-1-driven drug resistance in hematological malignancies: Mechanistic insights and advances in targeted therapy. | iScience | 2026 | 41816301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers